Sol-Gel Coating Controlled Antibiotic Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional antibacterial sol-gel coatings for orthopedic implants face challenges with coating integrity, antibiotic release control, and risk of toxic or allergic responses, particularly in cementless arthroplasty procedures where post-operative infections are a significant concern.

Innovation Solution

A sol-gel derived coating with an organic-inorganic oxide network encapsulates antimicrobials, allowing controlled release upon exposure to biological fluids, enhancing storage stability and maintaining antimicrobial functionality, while providing a durable and flexible interface for prosthetic implants.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antibiotic is incorporated within cement matrix to prevent post operative infections, then infection rate is reduced, but antibiotic release into bloodstream causes toxic and allergic responses

Engineering Contradiction:
Improveinfection preventionVSAvoidtoxic and allergic responses
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts the antibiotic from the cement matrix and relocates it to a sol-gel coating layer applied directly to the prosthetic surface. This separation allows the antibiotic to be positioned where it is most needed (at the implant-bone interface) while enabling controlled release kinetics that prevent systemic toxicity. The sol-gel matrix acts as a dedicated drug delivery vehicle independent of the structural cement.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The sol-gel coating forms a porous network structure that enables controlled diffusion of antibiotic molecules. The porosity allows biological fluids to penetrate and trigger sustained antibiotic release directly at the implant site, preventing infection without requiring high systemic concentrations that would cause toxic effects. The porous structure facilitates localised drug delivery with minimal systemic exposure.

Inventive Principle:
Principle #31Porous materials

2Stability of the object's composition

If sol-gel coating encapsulates antimicrobial for controlled release, then storage stability is enhanced, but coating integrity and release control remain challenging

Engineering Contradiction:
Improvestorage stabilityVSAvoidcoating integrity and release control
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent employs a composite sol-gel system combining organic and inorganic components (organically modified silanes with metal oxides). This composite structure provides both the structural integrity needed for coating stability and the controlled porosity required for reliable antibiotic release. The organic-inorganic hybrid network creates a stable matrix that maintains coating integrity while enabling predictable drug delivery kinetics.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent utilizes sol-gel processing parameters (pH, temperature, catalyst concentration, precursor ratios) to precisely control the network structure and porosity of the coating. By adjusting these parameters, the coating's physical and chemical properties are optimized to maintain stability during storage while ensuring controlled antibiotic release during implantation. The sol-gel transition and curing process allow fine-tuning of release kinetics.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The coating ensures sustained and controlled release of antimicrobials, reducing the risk of post-operative infections and maintaining implant stability over extended periods without adverse reactions, thus addressing the limitations of existing systems.

Implementation Method 1

a sol-gel derived coating and in particular, although not exclusively, to a solid organic-inorganic oxide network chemically bonded to a substrate

Methodology Applied
Scientific EffectSol-gel process: Gel

Implementation Method 2

an antimicrobial releasably captured within the organic-inorganic oxide network

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentEP2328627B1Antimicrobial coating
Publication Date: 2012.12.26 SHEFFIELD HALLAM UNIVERSITY
  • EP2328627B1 patent drawingFigure 1

AI summary

A substrate (100) comprising a sol-gel derived coating (101). The coating, is chemically bonded to the substrate (100) and is derived from a polysiloxane to form a network of silicon-carbon and silicon-oxygen bonds. An antimicrobial is releasably captured within the network and is capable of defusing from the coatingin vivo in response to introduction of a fluid into the coating.